SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-034698
Filing Date
2023-06-05
Accepted
2023-06-05 21:43:44
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6524
  Complete submission text file 0001209191-23-034698.txt   7933
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O DBV TECHNOLOGIES S.A. 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address
Ndu Adora (Reporting) CIK: 0001865210 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 23994747